Secreted Clever-1 modulates T cell responses and impacts cancer immunotherapy efficacy.

We observed a highly significant enrichment of sClever-1 in the plasma of patients with cancer compared to undiagnosed healthy donors ( Figure 1 B ).

also in 132,142 other papers